VITA 34 AG

FamiCord AG collects, processes, stores, and distributes cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. It operates through the Subgroup Vita 34 and Subgroup PBKM segments. The company develops advanced therapies, genetic tests, and analyses for third parties, and manufactures cell and tissue-based products and pharmaceuticals, including viral vectors. It also conducts research, development, storage, and cryopreservation of sperm and oocytes for reproductive medicine, and manufactures and distributes medical devices. Formerly known as VITA 34 AG, it changed its name to FamiCord AG in February 2025. Founded in 1997, it is headquartered in Leipzig, Germany.